Skip to main content
. 2017 Feb 27;9(2):61–67. doi: 10.4240/wjgs.v9.i2.61

Table 1.

Patient demographics

FL-HCC (n = 22)
Median age, years (range) 29 yr (21 to 58)
Male/female 11/11 (50%:50%)
Hepatitis or cirrhosis 2 (9%)
Elevated AFP (> 200 ng/mL) 2 (9%)

FL-HCC: Fibrolamellar hepatocellular carcinoma; AFP: Alpha-fetaprotein.